Innovative drugs targeting IDO1 functions in neoplasia

被引：0
|
作者：
Grohmann, U. [1 ]
Macchiarulo, A. [2 ]
机构：
[1] Univ Perugia, Perugia, Italy
[2] Univ Perugia, Dept Pharmaceut Sci, Perugia, Italy
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
基金：
欧洲研究理事会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2IN
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [41] Deleterious role of IDO1 in cardiac repair
    不详
    NATURE REVIEWS CARDIOLOGY, 2021, 18 (03) : 150 - 150
  • [42] Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors
    Meininger, David
    Zalameda, Leeanne
    Liu, Yichin
    Stepan, Lara P.
    Borges, Luis
    McCarter, John D.
    Sutherland, Claire L.
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2011, 1814 (12): : 1947 - 1954
  • [43] Superiority of dual IDO1/TDO2 inhibition versus IDO1 selective inhibition in reducing immunosuppressive KYN levels in tumors co-expressing IDO1 and TDO2
    Lotz-Jenne, Carina
    Cren, Sylvaine
    Joesch, Christoph
    Ackerknecht, Sabine
    Brandes, Jennifer
    Moebs, Claire
    Hartl, Dominik
    Hartrampf, Felix
    Guerry, Philippe
    Pothier, Julien
    Chavanton-Arpel, Alexia
    CANCER RESEARCH, 2023, 83 (07)
  • [44] Superiority of dual IDO1/TDO2 inhibition versus IDO1 selective inhibition in reducing immunosuppressive KYN levels in tumors co-expressing IDO1 and TDO2
    Lotz-Jenne, Carina
    Cren, Sylvaine
    Joesch, Christoph
    Ackerknecht, Sabine
    Brandes, Jennifer
    Moebs, Claire
    Hartl, Dominik
    Hartrampf, Felix
    Guerry, Philippe
    Pothier, Julien
    Chavanton-Arpel, Alexia
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12)
  • [45] Melanoma Cells Inhibit iNKT Cell Functions via PGE2 and IDO1
    Torre, Enza
    Pinton, Giulia
    Lombardi, Grazia
    Fallarini, Silvia
    CANCERS, 2023, 15 (13)
  • [46] Impact of IDO1 and IDO2 on the B Cell Immune Response
    Merlo, Lauren M. F.
    Peng, Weidan
    Mandik-Nayak, Laura
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] Discovery of novel IDO1 inhibitors targeting the protein's apo form through scaffold hopping from holo-IDO1 inhibitor
    Wu, Yunze
    Duan, Qizhu
    Zou, Yi
    Zhu, Qihua
    Xu, Yungen
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 52
  • [48] Amyloid β neurotoxicity is IDO1-Kyn-AhR dependent and blocked by IDO1 inhibitor
    Duan, Zhenzhen
    Zhang, Shengnan
    Liang, Heng
    Xing, Zikang
    Guo, Leilei
    Shi, Lei
    Du, Lisha
    Kuang, Chunxiang
    Takikawa, Osamu
    Yang, Qing
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [49] Dexmedetomidine Affects Triple-Negative Breast Cancer by Targeting IDO1 and CHRM3
    Luo, Jie
    Cao, Hong
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2024, 38 (03): : 2487 - 2501
  • [50] Synthesis and biological evaluation of new berberine derivatives as cancer immunotherapy agents through targeting IDO1
    Wang, Yan-Xiang
    Pang, Wei-Qiang
    Zeng, Qing-Xuan
    Deng, Zhe-Song
    Fan, Tian-Yun
    Jiang, Jian-Dong
    Deng, Hong-Bin
    Song, Dan-Qing
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 143 : 1858 - 1868
12345